Patrimonio netto: 700 705 $ in data 30/09/2026
Paul Hudson è amministratore delegato e direttore di Sanofi, presidente di Novartis Pharma KK e amministratore delegato e direttore di Sanofi Clir SENC. Fa parte del consiglio di amministrazione di Sanofi e Sanofi Clir SENC. Il signor Hudson è stato precedentemente impiegato come amministratore delegato di Novartis Pharmaceuticals Corp., presidente di AstraZeneca US & EVP-Nord America di AstraZeneca Plc, presidente di AstraZneca Farmacutica Spain SA, presidente e direttore di AstraZeneca KK, membro del comitato esecutivo di Novartis AG e responsabile del marketing globale di Schering Plough Holdings France SAS. Ha ricevuto la sua laurea presso la Manchester Metropolitan University di.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 19/10/2026 | 6.139 ( 0% ) | 700 705 $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| INSMED INCORPORATED | Direttore/Membro del Consiglio | 20/10/2026 |
Novartis Pharma KK
 Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Develops, imports, produces and markets pharmaceutical products | Presidente | - |
| Società | Posizione | Fine |
|---|---|---|
| SANOFI | Amministratore Delegato | 17/02/2026 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Amministratore Delegato | 01/01/2019 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/06/2016 |
Schering Plough Holdings France SAS
 Schering Plough Holdings France SAS Pharmaceuticals: OtherHealth Technology Manufactures healthcare products and medicines | Vendite & Marketing | - |
Sanofi Clir SNC
 Sanofi Clir SNC Medical DistributorsDistribution Services Wholesales pharmaceutical products | Amministratore Delegato | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Insmed, Inc.
 Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Manchester Metropolitan University
 Manchester Metropolitan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca KK
 AstraZeneca KK Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells medical drugs | Health Technology |
AstraZéneca Farmacéutica Spain SA
 AstraZéneca Farmacéutica Spain SA Pharmaceuticals: MajorHealth Technology Produces pharmaceutical products | Health Technology |
Novartis Pharma KK
Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Develops, imports, produces and markets pharmaceutical products | Health Technology |
Schering Plough Holdings France SAS
Schering Plough Holdings France SAS Pharmaceuticals: OtherHealth Technology Manufactures healthcare products and medicines | Health Technology |
Sanofi Clir SNC
Sanofi Clir SNC Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
